Musunuri Shankar

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return64%4%(22%)(31%)0%
Purchase Success Rate1 of 11 of 10 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 60 of 60 of 60 of 60 of 6

Ocugen, Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 3.16M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--